Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

29 trials with published results (10%)

Research Maturity

167 completed trials (55% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.6%

17 terminated out of 303 trials

Success Rate

90.8%

+4.2% vs benchmark

Late-Stage Pipeline

23%

69 trials in Phase 3/4

Results Transparency

17%

29 of 167 completed with results

Key Signals

29 with results91% success17 terminated

Data Visualizations

Phase Distribution

182Total
Not Applicable (52)
Early P 1 (3)
P 1 (37)
P 2 (21)
P 3 (30)
P 4 (39)

Trial Status

Completed167
Unknown60
Recruiting32
Terminated17
Not Yet Recruiting11
Active Not Recruiting9

Trial Success Rate

90.8%

Benchmark: 86.6%

Based on 167 completed trials

Clinical Trials (303)

Showing 20 of 20 trials
NCT03483181WithdrawnPrimary

Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Using Propensity Score Matching

NCT06329921Not ApplicableCompleted

Inpatient Monitoring of Unfractionated Heparin

NCT07519304Not ApplicableActive Not Recruiting

Effectiveness of a Needle-free Connector With Anti-reflux Technology in Reducing Complications From Long Peripheral Venous Catheters in Hospitalised Adult Patients: Randomised Clinical Trial

NCT06113510Recruiting

Non-invasive Coronary Thrombus Imaging to Define These Cause of Acute Myocardial Infarction

NCT07613840Not ApplicableRecruiting

Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease

NCT05636748Recruiting

The Origin and Role of Thromboembolism in the Pathogenesis of Ischaemic Stroke

NCT07813377Recruiting

Usefulness of Thromboelastography as a Predictor of Prognosis in Patients Undergoing Surgery for Glial Tumors and of the Risk of Postoperative Thromboembolic Disease (GliTEM)

NCT07597239Not ApplicableActive Not RecruitingPrimary

Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization

NCT07372716Not ApplicableRecruitingPrimary

Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study)

NCT07498517Phase 2RecruitingPrimary

Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT

NCT06386107Not ApplicableRecruiting

Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis

NCT04398628Recruiting

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

NCT06062329Not ApplicableCompleted

SYMPHONY-PE Study for Treatment of Pulmonary Embolism

NCT07137429RecruitingPrimary

Platelet Volunteers, Longitudinal and Multi-omic Study

NCT06993740Not ApplicableCompleted

Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient

NCT03161678Phase 4Completed

CES1 Crossover Trial of Clopidogrel and Ticagrelor

NCT06370273Phase 3RecruitingPrimary

Thromboprophylaxis in Lower Limb Immobilisation

NCT06694779Completed

Thrombosis in Diffuse Large B-cell Lymphoma:the PREDIC-TO (PREDICt ThrOmbosis) Study

NCT07580469Not Yet Recruiting

Platelets and Extracorporeal Membrane Oxygenation Veno-venous

NCT06357403RecruitingPrimary

Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients

Scroll to load more

Research Network

Activity Timeline